Langerhans cell histiocytosis: A pathologic combination of oncogenesis and immune dysregulation
- 6 February 2004
- journal article
- editorial
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 42 (5) , 401-403
- https://doi.org/10.1002/pbc.10464
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Aberrant Chemokine Receptor Expression and Chemokine Production by Langerhans Cells Underlies the Pathogenesis of Langerhans Cell HistiocytosisThe Journal of Experimental Medicine, 2003
- Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosisBlood, 2003
- Langerhans-cell histiocytosis 'insight into DC biology'Trends in Immunology, 2003
- Inflammation and cancerNature, 2002
- p53 Expression in Biopsies From Children With Langerhans Cell HistiocytosisJournal of Pediatric Hematology/Oncology, 2002
- Differentiation of Langerhans cells in Langerhans cell histiocytosisBlood, 2001
- Cytogenetic abnormalities in PHA-stimulated lymphocytes from patients with Langerhans cell histiocytosisBritish Journal of Haematology, 2000
- LANGERHANS CELL HISTIOCYTOSIS RESEARCH: Past, Present, and FutureHematology/Oncology Clinics of North America, 1998
- Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative DiseaseNew England Journal of Medicine, 1994
- Clonal proliferation of Langerhans cells in Langerhans cell histiocytosisPublished by Elsevier ,1994